Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ Scientia, Dipòsit d’...arrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
versions View all 4 versions
addClaim

This Research product is the result of merged Research products in OpenAIRE.

You have already added 0 works in your ORCID record related to the merged Research product.

Millora del compliment terapèutic: una bona forma d’iniciar la coordinació amb les oficines de farmàcia

Authors: Milozzi Berrocal, Jordi; Isnard Blanchar, Mar; Martín, Maribel; Iracheta Todó, Montserrat;

Millora del compliment terapèutic: una bona forma d’iniciar la coordinació amb les oficines de farmàcia

Abstract

Sistema personalitzat de dosificació; Oficines de farmàcia; Compliment terapèutic Sistema personalizado de dosificación; Oficinas de farmacia; Cumplimiento terapéutico Custom Dosing System; Pharmacy Office; Therapeutic compliance Els diferents agents de salut tenen la responsabilitat d’ajudar el pacient a millorar la seva adaptació a la malaltia, i així aconseguir bons resultats de salut. Farmacèutics comunitaris i professionals sanitaris d’atenció primària poden portar a terme projectes comuns per tal d’aconseguir aquest objectiu. L'article parla del mètode de millora de compliment anomenat Sistema personalitzat de dosificació (SPD) que utilitzen les oficines de farmàcia de la ciutat de Santa Coloma de Gramenet. Los diferentes agentes de salud tienen la responsabilidad de ayudar al paciente a mejorar su adaptación a la enfermedad, y así conseguir buenos resultados de salud. Farmacéuticos comunitarios y profesionales sanitarios de atención primaria pueden llevar a cabo proyectos comunes para conseguir este objetivo. El artículo habla del método de mejora de cumplimiento llamado Sistema personalizado de dosificación (SPD) que utilizan las oficinas de farmacia de la ciudad de Santa Coloma de Gramenet.

Keywords

:Otros calificadores::Otros calificadores::/administración & dosificación [Otros calificadores], :control sanitario de productos::control de medicamentos y estupefacientes::preparados farmacéuticos [VIGILANCIA SANITARIA], :Atención a la Salud::Atención a la Salud::Servicios de Salud::Servicios Farmacéuticos [SALUD PÚBLICA], :Health Surveillance of Products::Drug and Narcotic Control::Pharmaceutical Preparations [HEALTH SURVEILLANCE], Farmàcia, :atención a la salud (salud pública)::atención a la salud (salud pública)::servicios de salud::servicios farmacéuticos [SALUD PÚBLICA], :Other subheadings::Other subheadings::/administration & dosage [Other subheadings], :Vigilancia Sanitaria de Productos::Control de Medicamentos y Narcóticos::Preparaciones Farmacéuticas [VIGILANCIA SANITARIA], Posologia, :Health Care (Public Health)::Health Care (Public Health)::Health Services::Pharmaceutical Services [PUBLIC HEALTH]

11 references, page 1 of 2

1. Nissen SE. ADHD Drugs and Cardiovascular Risk. N Eng J Med. 2006;354:1445-8.

2. Janssen-Cilag. www.trastornohiperactividad.com (juny 2007).

3. Anónimo. La cocaína pediátrica y el TDAH. www.equinoxio.org/columnas/lacocaina-pediatrica-y-el-tdah-802-802/ (juny 2007).

4. Anónimo. Tratamiento del trastorno por déficit de atención con hiperactividad pediátrico. Bol Ter Andal. 2004;20(6);21-24.

5. Anónimo. Trastorno por déficit de atención con/sin hiperactividad (TDAH) en el niño-adolescente. Infac. 2006;14(9):37-42.

6. NICE. Methylphenidate, atomoxetine and dexamfetamine for the treatment of attention deficit hyperactivity disorder in children and adolescents. NICE Technology Appraisal Guidance 98. March 2006. London: National Institute for Clinical Excellence. www.nice.org.uk (jun 2007).

7. Schmidt-Troschke SO, Ostermann T, Melcher D, et al. The use of methylphenidate in children: analysis of prescription usage based in routine data of statutory health insurance bodies concerning drug prescriptions. Gesundheitswesen 2004;66(6):387-92.

8. Wilens TE, Biederman J, Brown S et al. Psychiatric comorbidity and functioning in clinically referred preschool children and school-age youths with ADHD. J Am Acad Child Adolesc Psychiatry. 2002;41(3):262-8.

9. Okie S. ADHD in adults. NEJM. 2006;354:2367-41. [OpenAIRE]

10.Handen BL, Feldamn HM, Lurier A, Murray PJ. Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD. J Am Child Adolesc Psychiatr. 1999;38:805-12.

  • BIP!
    Impact byBIP!
    citations
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
  • citations
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
    Powered byBIP!BIP!
Powered by OpenAIRE graph
Found an issue? Give us feedback
citations
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average